Published in Cancer Weekly, September 30th, 1996
In a study released in the September 1996 issue of Gynecologic Oncology, physicians used Hybrid Capture - technology that can reliably detect human papillomavirus (HPV) infection - on a population of women who had already received abnormal pap smears. HPV infection can be associated with 93 percent of all cervical cancer cases. The researchers compared these "molecular" findings with the diagnostic gold standard, the cervix biopsy.
The U.S. Food and Drug Administration (FDA)-approved Hybrid Capture test found every...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.